11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6307/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :18/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "IMMULOMODULATORY COMPOUNDS AND TREATMENT OF DISEASES RELATED TO AN<br />

OVERPRODUCTION OF INFLAMMATORY CYTOKINES"<br />

(51) International classification : C07D 471/06 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :PCT/IB2006/050748 1)OM PHARMA<br />

(32) Priority Date :09/03/2006<br />

Address <strong>of</strong> Applicant :22, RUE DU BOIS-DU-LAN,<br />

(33) Name <strong>of</strong> priority country :EPO<br />

P.O.BOX 84, CH-1217 MEYRIN 2 SWITZERLAND.<br />

(86) International Application No :PCT/IB2007/000567 Switzerl<strong>and</strong><br />

Filing Date<br />

:09/03/2007 (72)Name <strong>of</strong> Inventor :<br />

(87) International Publication No :WO 2007/102081 1)BAUER JACQUES<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

2)CHIAVAROLI CARLO<br />

3)MOUTEL STEPHANE<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The invention relates to the use <strong>of</strong> immunomodulatory compounds for the treatment <strong>of</strong> diseases related to to an overproduction <strong>of</strong><br />

inflammatory cytokines, such as diseases selected <strong>from</strong> the group consisting <strong>of</strong> asthma, atopic dermatitis, allergic rhinitis, prostatitis,<br />

inflammatory bowel disease, diabetes, <strong>and</strong> rhumatoid arthritis, said compounds being <strong>of</strong> general formula (I), wherein : m <strong>and</strong> n,<br />

independently <strong>from</strong> each other, are an integer ranging <strong>from</strong> 1 to 4, X <strong>and</strong> Y represent -COOH, -0-P(O)(OH)2, -O- SO2(OH), -NH2, -<br />

OH, -CONH(CH2)ni-NH2, -CO-NH-CH(COOH)- (CH2)n1COOH, -CO-NH-CH(COOH)- (CH2)n1-NH2, -0-CO-(CH2)n1NH2,-0-<br />

CO-(CH2)n1-CHOH-CH2OH, -0-CO-(CH2)n1-OH, -0-CO-(CH2)n1-COOH, -O- CO-(CH2)nrCHO, -0-CO-(CH2)n1-NH-CO-<br />

(CH2)n2-COOH, R-, <strong>and</strong> R2 each designate an acyl group derived <strong>from</strong> a saturated or unsaturated, straight- or branched-chain<br />

carboxylic acid having <strong>from</strong> 2 to 18 carbon atoms, which is unsubstituted or bears one to three substituents selected among hydroxyl,<br />

dihydroxyphosphoryloxy, alkyl <strong>of</strong> 2 to 18 carbon atoms, alkoxy <strong>of</strong> 2 to 18 carbon atoms, acyloxy <strong>of</strong> 2 to 18 carbon atoms in the acyl<br />

moiety, amino, acylamino.<br />

No. <strong>of</strong> Pages : 65 No. <strong>of</strong> Claims : 13<br />

The Patent Office Journal 24/10/2008 25782

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!